First Patient Enrolled in Penumbra's FORWARD Study Evaluating Mechanical Thrombectomy and Computer Assisted Vacuum Thrombectomy for Distal Acute Ischemic Stroke

In Alameda, California, on July 7, 2026, Penumbra, Inc. (NYSE: PEN), a top thrombectomy company globally, launched the FORWARD study. This study, conducted at multiple centers internationally, will gather data on the safety and effectiveness of mechanical procedures.